volume 50 issue 12 pages 2976-2985

The Evolution of Chemical High-Throughput Experimentation To Address Challenging Problems in Pharmaceutical Synthesis

Daniel A Dirocco 2
Spencer D. Dreher 1
1
 
Chemistry Capabilities and Screening, Merck Sharp & Dohme Corporation, Kenilworth, New Jersey 07033, United States
2
 
Process Research & Development, Merck Sharp & Dohme Corporation, Rahway, New Jersey 07065, United States
Publication typeJournal Article
Publication date2017-11-27
scimago Q1
wos Q1
SJR5.433
CiteScore30.7
Impact factor17.7
ISSN00014842, 15204898
General Chemistry
General Medicine
Abstract
The structural complexity of pharmaceuticals presents a significant challenge to modern catalysis. Many published methods that work well on simple substrates often fail when attempts are made to apply them to complex drug intermediates. The use of high-throughput experimentation (HTE) techniques offers a means to overcome this fundamental challenge by facilitating the rational exploration of large arrays of catalysts and reaction conditions in a time- and material-efficient manner. Initial forays into the use of HTE in our laboratories for solving chemistry problems centered around screening of chiral precious-metal catalysts for homogeneous asymmetric hydrogenation. The success of these early efforts in developing efficient catalytic steps for late-stage development programs motivated the desire to increase the scope of this approach to encompass other high-value catalytic chemistries. Doing so, however, required significant advances in reactor and workflow design and automation to enable the effective assembly and agitation of arrays of heterogeneous reaction mixtures and retention of volatile solvents under a wide range of temperatures. Associated innovations in high-throughput analytical chemistry techniques greatly increased the efficiency and reliability of these methods. These evolved HTE techniques have been utilized extensively to develop highly innovative catalysis solutions to the most challenging problems in large-scale pharmaceutical synthesis. Starting with Pd- and Cu-catalyzed cross-coupling chemistry, subsequent efforts expanded to other valuable modern synthetic transformations such as chiral phase-transfer catalysis, photoredox catalysis, and C-H functionalization. As our experience and confidence in HTE techniques matured, we envisioned their application beyond problems in process chemistry to address the needs of medicinal chemists. Here the problem of reaction generality is felt most acutely, and HTE approaches should prove broadly enabling. However, the quantities of both time and starting materials available for chemistry troubleshooting in this space generally are severely limited. Adapting to these needs led us to invest in smaller predefined arrays of transformation-specific screening "kits" and push the boundaries of miniaturization in chemistry screening, culminating in the development of "nanoscale" reaction screening carried out in 1536-well plates. Grappling with the problem of generality also inspired the exploration of cheminformatics-driven HTE approaches such as the Chemistry Informer Libraries. These next-generation HTE methods promise to empower chemists to run orders of magnitude more experiments and enable "big data" informatics approaches to reaction design and troubleshooting. With these advances, HTE is poised to revolutionize how chemists across both industry and academia discover new synthetic methods, develop them into tools of broad utility, and apply them to problems of practical significance.
Found 
Found 

Top-30

Journals

5
10
15
20
Organic Process Research and Development
20 publications, 7.43%
Angewandte Chemie - International Edition
15 publications, 5.58%
Angewandte Chemie
15 publications, 5.58%
Journal of the American Chemical Society
14 publications, 5.2%
Journal of Organic Chemistry
13 publications, 4.83%
ACS Catalysis
13 publications, 4.83%
Nature Communications
9 publications, 3.35%
Reaction Chemistry and Engineering
8 publications, 2.97%
Chemical Science
7 publications, 2.6%
Digital Discovery
6 publications, 2.23%
Chemistry - A European Journal
5 publications, 1.86%
Chemical Reviews
5 publications, 1.86%
ACS Medicinal Chemistry Letters
5 publications, 1.86%
Accounts of Chemical Research
4 publications, 1.49%
RSC Medicinal Chemistry
4 publications, 1.49%
Chemistry - Methods
3 publications, 1.12%
Nature Chemistry
3 publications, 1.12%
Chem
3 publications, 1.12%
Tetrahedron
3 publications, 1.12%
Organometallics
3 publications, 1.12%
ACS Central Science
3 publications, 1.12%
Organic Letters
3 publications, 1.12%
Chemical Communications
3 publications, 1.12%
Science
3 publications, 1.12%
Nature Synthesis
3 publications, 1.12%
Inorganic Chemistry
2 publications, 0.74%
Nature Protocols
2 publications, 0.74%
Scientific Reports
2 publications, 0.74%
Communications Chemistry
2 publications, 0.74%
5
10
15
20

Publishers

10
20
30
40
50
60
70
80
90
100
American Chemical Society (ACS)
97 publications, 36.06%
Wiley
53 publications, 19.7%
Royal Society of Chemistry (RSC)
38 publications, 14.13%
Springer Nature
37 publications, 13.75%
Elsevier
23 publications, 8.55%
MDPI
7 publications, 2.6%
American Association for the Advancement of Science (AAAS)
4 publications, 1.49%
Georg Thieme Verlag KG
2 publications, 0.74%
Beilstein-Institut
2 publications, 0.74%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 0.37%
Research Square Platform LLC
1 publication, 0.37%
Taylor & Francis
1 publication, 0.37%
Mary Ann Liebert
1 publication, 0.37%
Institute of Electrical and Electronics Engineers (IEEE)
1 publication, 0.37%
10
20
30
40
50
60
70
80
90
100
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
269
Share
Cite this
GOST |
Cite this
GOST Copy
Krska S. W. et al. The Evolution of Chemical High-Throughput Experimentation To Address Challenging Problems in Pharmaceutical Synthesis // Accounts of Chemical Research. 2017. Vol. 50. No. 12. pp. 2976-2985.
GOST all authors (up to 50) Copy
Krska S. W., Dirocco D. A., Dreher S. D., Shevlin M. The Evolution of Chemical High-Throughput Experimentation To Address Challenging Problems in Pharmaceutical Synthesis // Accounts of Chemical Research. 2017. Vol. 50. No. 12. pp. 2976-2985.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1021/acs.accounts.7b00428
UR - https://doi.org/10.1021/acs.accounts.7b00428
TI - The Evolution of Chemical High-Throughput Experimentation To Address Challenging Problems in Pharmaceutical Synthesis
T2 - Accounts of Chemical Research
AU - Krska, Shane W.
AU - Dirocco, Daniel A
AU - Dreher, Spencer D.
AU - Shevlin, Michael
PY - 2017
DA - 2017/11/27
PB - American Chemical Society (ACS)
SP - 2976-2985
IS - 12
VL - 50
PMID - 29172435
SN - 0001-4842
SN - 1520-4898
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2017_Krska,
author = {Shane W. Krska and Daniel A Dirocco and Spencer D. Dreher and Michael Shevlin},
title = {The Evolution of Chemical High-Throughput Experimentation To Address Challenging Problems in Pharmaceutical Synthesis},
journal = {Accounts of Chemical Research},
year = {2017},
volume = {50},
publisher = {American Chemical Society (ACS)},
month = {nov},
url = {https://doi.org/10.1021/acs.accounts.7b00428},
number = {12},
pages = {2976--2985},
doi = {10.1021/acs.accounts.7b00428}
}
MLA
Cite this
MLA Copy
Krska, Shane W., et al. “The Evolution of Chemical High-Throughput Experimentation To Address Challenging Problems in Pharmaceutical Synthesis.” Accounts of Chemical Research, vol. 50, no. 12, Nov. 2017, pp. 2976-2985. https://doi.org/10.1021/acs.accounts.7b00428.